Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Degenring

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|March 3, 2004
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]J B Jonas, I Kreissig, B Kamppeter, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 25, 2008
[Intravitreal bevacizumab for chronic central serous chorioretinopathy]M F Niegel, N F Schrage, S Christmann, et al.
European Journal of Ophthalmology|June 10, 2005
Cataract surgery combined with intravitreal injection of triamcinolone acetonideJ B Jonas, I Kreissig, W M Budde, et al.
Eye (London, England)|June 26, 2004
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized studyJ B Jonas, R F Degenring, I Kreissig, et al.
Eye (London, England)|April 24, 2004
Branch retinal vein occlusion treated by intravitreal triamcinolone acetonideJ B Jonas, I Akkoyun, B Kamppeter, et al.
European Journal of Ophthalmology|December 6, 2005
Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusionJ B Jonas, I Akkoyun, B Kamppeter, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|March 3, 2004
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]J B Jonas, I Kreissig, B Kamppeter, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|January 25, 2008
[Intravitreal bevacizumab for chronic central serous chorioretinopathy]M F Niegel, N F Schrage, S Christmann, et al.
European Journal of Ophthalmology|June 10, 2005
Cataract surgery combined with intravitreal injection of triamcinolone acetonideJ B Jonas, I Kreissig, W M Budde, et al.
Eye (London, England)|June 26, 2004
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized studyJ B Jonas, R F Degenring, I Kreissig, et al.
Eye (London, England)|April 24, 2004
Branch retinal vein occlusion treated by intravitreal triamcinolone acetonideJ B Jonas, I Akkoyun, B Kamppeter, et al.
European Journal of Ophthalmology|December 6, 2005
Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusionJ B Jonas, I Akkoyun, B Kamppeter, et al.
Pageof 2